These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines. Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952 [TBL] [Abstract][Full Text] [Related]
3. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats. Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053 [TBL] [Abstract][Full Text] [Related]
4. GHB, GBL and 1,4-BD addiction. Brunt TM; van Amsterdam JG; van den Brink W Curr Pharm Des; 2014; 20(25):4076-85. PubMed ID: 24001290 [TBL] [Abstract][Full Text] [Related]
5. A review of evidence leading to the prediction that 1,4-butanediol is not a carcinogen. Irwin RD J Appl Toxicol; 2006; 26(1):72-80. PubMed ID: 16193534 [TBL] [Abstract][Full Text] [Related]
6. Neuropharmacological profile of tetrahydrofuran in mice. Werawattanachai N; Towiwat P; Unchern S; Maher TJ Life Sci; 2007 Apr; 80(18):1656-63. PubMed ID: 17331547 [TBL] [Abstract][Full Text] [Related]
7. Gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol addiction: a serious health threat. Beck R; Matanović SM; Zibar L Arh Hig Rada Toksikol; 2019 Jun; 70(2):149-150. PubMed ID: 31246568 [No Abstract] [Full Text] [Related]
13. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden]. Knudsen K; Greter J; Verdicchio M; Cederquist T Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543 [TBL] [Abstract][Full Text] [Related]
14. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Lenz D; Rothschild MA; Kröner L Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955 [TBL] [Abstract][Full Text] [Related]
15. 4-methylpyrazole decreases 1,4-butanediol toxicity by blocking its in vivo biotransformation to gamma-hydroxybutyric acid. Quang LS; Desai MC; Shannon MW; Woolf AD; Maher TJ Ann N Y Acad Sci; 2004 Oct; 1025():528-37. PubMed ID: 15542758 [TBL] [Abstract][Full Text] [Related]
16. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639 [TBL] [Abstract][Full Text] [Related]
17. Gamma-hydroxybutyric acid and its relevance in neurology. Benarroch EE Neurology; 2009 Jan; 72(3):282-6. PubMed ID: 19153376 [No Abstract] [Full Text] [Related]
18. High affinity binding site for gamma-hydroxybutyric acid in rat brain. Maitre M; Rumigny JF; Benavides J; Bourguignon JJ; Wermuth CG; Cash C; Mandel P Adv Biochem Psychopharmacol; 1983; 37():441-53. PubMed ID: 6314770 [No Abstract] [Full Text] [Related]
19. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand. Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613 [TBL] [Abstract][Full Text] [Related]
20. Receptors, neurotransmitters and drug responses. Snyder SH N Engl J Med; 1979 Mar; 300(9):465-72. PubMed ID: 32488 [No Abstract] [Full Text] [Related] [Next] [New Search]